Amie Batson, MBA, is responsible for guiding PATH’s strategy, strengthening our partnerships and business relationships in the global health community, and contributing to our advocacy and policy priorities.
Ms. Batson’s 20-year career in global health includes positions with the World Health Organization, UNICEF, the World Bank, and most recently, the US Agency for International Development (USAID), where she served as senior deputy assistant administrator for global health.
During her three-year appointment with USAID, Ms. Batson led the agency’s engagement in the President’s Global Health Initiative, represented the US government on the board of the GAVI Alliance, and led the US government team in coconvening the Child Survival Call to Action, which launched the global vision to end preventable child deaths.
Throughout her career in global health, Ms. Batson has been a leader in innovation. Her contributions to immunization and vaccine financing at the World Bank resulted in billions of dollars in new funding for global health and the vaccination of millions of children against polio, pneumonia, diarrhea, and other vaccine-preventable causes of death.
Ms. Batson earned a BA in economics from the University of Virginia and a MBA from the Yale University School of Management.
President of Global Development, Bill & Melinda Gates Foundation
As President of the Global Development Program at the Bill & Melinda Gates Foundation, Dr. Chris Elias leads the Foundation’s efforts in integrated and innovative delivery, finding creative new ways to ensure solutions and products get into the hands of people in developing countries who need them most. Focusing on areas with the potential for high-impact, sustainable solutions that can reach hundreds of millions of people, Dr. Elias oversees Global Development’s portfolio in Agriculture Development; Family Planning; Financial Services for the Poor; Maternal, Newborn, & Child Health; Polio; Vaccines Delivery; Water, Sanitation & Hygiene; and Special Initiatives.
Dr. Elias’s professional background is in health and medicine, most recently having served as the president and CEO of PATH, an international, nonprofit organization dedicated to improving the health of people around the world by advancing technologies, strengthening systems, and encouraging healthy behaviors. Elias currently serves on various advisory boards, including the Nike Foundation and the Duke Global Health Institute.
Professor of the Practice of Global Health and Public Policy, Associate Director for Policy and Director of the Center for Policy Impact Global Health at the Duke Global Health Institute
Gavin Yamey is Professor of the Practice of Global Health and Public Policy, Associate Director for Policy, and Director of The Center for Policy Impact in Global Health at the Duke Global Health Institute. He directs the Global Health Fellowship Program in Duke’s Geneva Program on Global Policy and Governance. He trained in clinical medicine at Oxford University and University College London, medical journalism and editing at the BMJ and public health at the London School of Hygiene and Tropical Medicine. He was Deputy Editor of the Western Journal of Medicine, Assistant Editor at the BMJ, a founding Senior Editor of PLOS Medicine, and the Principal Investigator on a $1.1 million grant from the Bill & Melinda Gates Foundation to support the launch of PLOS Neglected Tropical Diseases. In 2009, he was a Kaiser Family Foundation Fellow in Global Health Reporting, and examined the barriers to scaling up low cost health tools in Sudan, Uganda, and Kenya. Yamey serves on the Lancet Commission on Investing in Health and the Lancet Commission on Global Surgery. He has been an External Advisor to the WHO. He has published extensively on global health, neglected diseases, and disparities in health and has been a frequent commentator on National Public Radio. Before joining Duke, he led the Evidence-to-Policy Initiative in the Global Health Group at the University of California, San Francisco (UCSF).
Molly Joel Coye
Social Entrepreneur in Residence, Network for Excellence in Health Innovation/NEHI
Dr. Molly Joel Coye is Social Entrepreneur in Residence for the Network for Excellence in Health Innovation (NEHI), a nonprofit national health policy institute focused on advancing high-value innovations. From 2010 – 2015, Dr. Coye was the Chief Innovation Officer for UCLA Health, heading the Institute for Innovation in Health and the Global Lab for Innovation. Dr. Coye was previously the founder and CEO of the Health Technology Center (HealthTech), a non-profit education and research organization established in 2000 that became the premier forecasting organization for emerging technologies in healthcare, as well as Commissioner of Health for the State of New Jersey, Director of the California State Department of Health Services, and Head of the Division of Public Health Practice at the Johns Hopkins School of Hygiene and Public Health. Dr. Coye is a member of the Institute of Medicine, and of the board of directors for Aetna, Inc., Prosetta Biosciences, Inc., Big White Wall, and ACCESS Health International. She previously served as Chair of the Board of Directors for PATH, one of the largest nonprofit organizations in global health, and on the boards of the American Hospital Association, the American Telemedicine Association, the American Public Health Association, and the China Medical Board. Dr. Coye holds MD and MPH degrees from Johns Hopkins University and a Master of Asian History from Stanford University.
Founder and Managing Partner of DBL Partners
Nancy E. Pfund is Founder and Managing Partner of DBL Partners (formerly Investors), a venture capital firm whose goal is to combine top-tier financial returns with meaningful social, economic and environmental returns in the regions and sectors in which it invests. As a leading player in the “impact investing” space, DBL has helped to reveal the power of venture capital to promote social change and environmental improvement. Ms. Pfund currently sponsors or sits on the board of directors of several companies, including; SolarCity (NASDAQ: SCTY), where she is Chair of the governance committee and sits on both the audit and compensation committees, Primus Power, Powergenix, Farmers Business Network, The Muse, Advanced Microgrid Solutions and Off-Grid Electric, and, prior to their public offerings, Tesla Motors and Pandora Media. Prior to founding DBL, Ms. Pfund was a Managing Director in Venture Capital at JPMorgan, having started her investment career at Hambrecht & Quist in 1984.